AbCellera.
company in Vancouver, Canada
- Reports this week
- 1
- Active events
- 1
- Connections
- 42
What's happening
Active this week
Earlier this month
One to three months ago
Gone quiet
No new reports in 90+ days-
Vertex and AbCellera are collaborating to advance T cell therapies (TCEs) for autoimmune diseases.Some support2 reports1 development inside
-
AbCellera announced that its Phase II clinical trial data exceeded expectations for blockbuster potential on August 11, 2026.Some support1 report
-
AbCellera debuted on the Nasdaq stock exchange on August 4, 2026.Some support1 report
-
Competitors acquired companies involved in the same market, and Lynn Seely was appointed to the company's Board of Directors.Some support1 report
-
Partnership between Jazz Pharmaceuticals, AbCellera, and PharmaMar leverages an antibody discovery engine for a biopharmaceutical based in Ireland.Well supported4 reports
-
AbCellera and Jazz Pharmaceuticals are both companies operating within the biomedical industry.Some support1 report
-
AbCellera and Bruker are involved in ongoing multi-patent infringement litigation.Speculative1 report
-
Leerink Partners affirmed an Outperform rating on AbCellera.Some support1 report
No events began in the chosen period. Widen it, or reset.
Around AbCellera this week
News at the entities that move AbCellera most-
FDA StructuralFDA issued a warning letter to NeoGen regarding a product quality defect on October 7, 2026.Moves AbCellera
-
Bruker StructuralSector-wide demand for scientific instruments is noted, involving Agilent Technologies and Bruker.Moves AbCellera
-
Cantor Fitzgerald Mentioned togetherCantor Fitzgerald raised its target price for Apple Hospitality REIT (APLE) on June 18th.Moves AbCellera
-
Benchmark TransactionalMillerKnoll shares traded on Nasdaq and Benchmark upgraded its stock rating on October 31, 2026.Moves AbCellera
-
Sanofi OperationalAgomAb completed its IPO on Nasdaq, while Sanofi joined a Series D funding round.Moves AbCellera
-
Nasdaq Shared contextGolub Capital BDC, Inc. listed on the electronic stock exchange.Moves AbCellera
Connections
The 17 strongest of 42, analyzed from the reporting. The bars show how strongly a change on one side reaches the other.-
Jazz Pharmaceuticals Operational
The companies maintain an active partnership focused on joint collaboration and development of multispecific antibodies.
-
Bruker Structural
AbCellera is linked to Bruker via a subsidiary relationship, while also being involved in patent infringement litigation.
-
Vertex Operational
The companies are engaged in a strategic collaboration to develop Targeted Cell Engagements (TCEs) for autoimmune diseases.
-
FDA Structural
The FDA functions as the primary regulatory body whose decisions govern the market viability and operational status of AbCellera.
-
Benchmark Transactional
Benchmark upgraded AbCellera's stock rating.
-
Sanofi Operational
The entities are competitors operating in the same market, driven by market acquisitions and consolidation.
-
Rio de Janeiro Shared context
AbCellera is temporarily located in Rio de Janeiro to present data at a conference.
-
investing.com Mentioned together
investing.com reports on AbCellera's financial performance.
Show all 17 connections
-
TMS Operational
AbCellera presented data at a meeting hosted by TMS.
-
British Columbia Shared context
AbCellera operates and is headquartered in British Columbia.
-
Cantor Fitzgerald Mentioned together
Cantor Fitzgerald provides investment coverage and research reports on AbCellera.
-
Jefferies Financial Group Mentioned together
Jefferies Financial Group provided coverage and a buy rating for AbCellera.
-
Nasdaq Shared context
AbCellera is a company whose shares are listed and trade on the Nasdaq stock exchange.
-
Truist Financial Mentioned together
Truist Financial issued a buy rating and increased the target price for AbCellera.
-
Vertex Transactional
Vertex provided upfront payments to AbCellera.
-
Vancouver Shared context
AbCellera is headquartered and conducts business operations from its base in Vancouver, British Columbia.
-
London Shared context
AbCellera is scheduled to present at a conference held in London.
History
Events by the month they beganNovember 2026
1 eventOctober 2026
2 eventsAugust 2026
4 events- An FDA decision influenced AbCellera's stock climb, related to the company's work advancing immune treatments.
- Vertex and AbCellera are collaborating to advance T cell therapies (TCEs) for autoimmune diseases.
- AbCellera announced that its Phase II clinical trial data exceeded expectations for blockbuster potential on August 11, 2026.
- AbCellera debuted on the Nasdaq stock exchange on August 4, 2026.
Show 2 earlier months
July 2026
1 eventJune 2026
6 events- Cantor Fitzgerald issued a coverage report on AbCellera, a company whose shares trade on Nasdaq.
- AbCellera, a company, is based in Vancouver, British Columbia.
- Partnership between Jazz Pharmaceuticals, AbCellera, and PharmaMar leverages an antibody discovery engine for a biopharmaceutical based in Ireland.
- AbCellera and Jazz Pharmaceuticals are both companies operating within the biomedical industry.
- AbCellera and Bruker are involved in ongoing multi-patent infringement litigation.
- Leerink Partners affirmed an Outperform rating on AbCellera.